- Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau CNBC
- AMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDY PR Newswire
- New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows The New York Times
Brought to you by Google News. Read the rest of the article here